
Walgreens to pay up to $350 million in US opioid settlement
CNN
Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances.
Walgreens has agreed to pay up to $350 million in a settlement with the US Department of Justice, who accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances. The nationwide drugstore chain must pay the government at least $300 million and will owe another $50 million if the company is sold, merged or transferred before 2032, according to the settlement reached last Friday. The government’s complaint, filed in January in the US District Court for the Northern District of Illinois, alleges that Walgreens knowingly filled millions of illegal prescriptions for controlled substances between August 2012 and March 2023. These include prescriptions for excessive opioids and prescriptions filled significantly early. “We strongly disagree with the government’s legal theory and admit no liability,” Walgreens spokesperson Fraser Engerman said in a statement. “This resolution allows us to close all opioid related litigation with federal, state, and local governments and provides us with favorable terms from a cashflow perspective while we focus on our turnaround strategy.” Amid slumping store visits and shrinking market share, Walgreens announced it was closing 1,200 stores around the country last October. Rite Aid filed for bankruptcy at the end of 2023 as it was also dealing with losses and opioid lawsuit settlements. The US Department of Justice filed a similar lawsuit against CVS in December. The complaint says Walgreens pharmacists filled these prescriptions despite clear red flags that the prescriptions were highly likely to be invalid, and the company pressured its pharmacists to fill them quickly. The government alleges Walgreen’s compliance officials ignored “substantial evidence” that its stores were filling unlawful prescriptions and withheld important information on opioid prescribers from its pharmacists.

The staggering and exceedingly public rupture in the world’s most consequential and unprecedented partnership was a long time coming. But the surreal state of suspended animation that consumed Washington as President Donald Trump and Elon Musk traded escalating blows on social media obscured a 48-hour period that illustrated profoundly high-stakes moment for the White House.

Part of the massive domestic policy bill currently moving through Congress known as the “Big Beautiful Bill,” includes an unprecedented $5 billion national school voucher program. Republicans have long advocated for so-called school choice, but critics have labeled the initiative a tax cut for the wealthy.